| BOLT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BOLT shares outstanding history going back to 2/5/2021:
Also see: BOLT Market Cap History BOLT YTD Return |

| BOLT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BOLT shares outstanding history going back to 2/5/2021:
Also see: BOLT Market Cap History BOLT YTD Return |
| BOLT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
BOLT Historical Shares Outstanding: +3.77% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| BOLT Stock Price Chart |
| About Bolt Biotherapeutics Inc |
| Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Co.'s pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. Trastuzumab imbotolimod is in Phase 2 clinical. BDC-3042, an agonist antibody targeting Dectin-2, is in a Phase 1 dose-escalation trial. We show 21 historical shares outstanding datapoints in our coverage of BOLT's shares outstanding history. Understanding the changing numbers of BOLT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BOLT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BOLT by allowing them to research BOLT shares outstanding history as well as any other stock in our coverage universe. |
| BOLT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| BOLT Share Performance |
| Shares Outstanding Peers |
| Bolt Biotherapeutics (BOLT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BPMC Shares Outstanding History BPTH Shares Outstanding History BRKR Shares Outstanding History BRTX Shares Outstanding History BSGM Shares Outstanding History BSPM Shares Outstanding History BSTC Shares Outstanding History BSX Shares Outstanding History BTAI Shares Outstanding History BTCY Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.